Neuphoria Therapeutics (NEUP) Restructuring Costs (2025 - 2026)
Neuphoria Therapeutics (NEUP) reported Restructuring Costs of $133,369 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 214.4% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Restructuring Costs (2025 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics posted Restructuring Costs of $1.41 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.23 Bn | 1,138.82 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 648.85 Bn | 568.71 Bn | 17.30 Bn |
| 3 | AbbVie | 504.91 Bn | 478.02 Bn | 12.70 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.65 Bn | 242.33 Bn | 12.86 Bn |
| 7 | Amgen | 242.96 Bn | 198.36 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn |
| 9 | Pfizer | 173.22 Bn | 119.87 Bn | 10.94 Bn |
| 10 | Neuphoria Therapeutics | 437.56 Mn | 362.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133,369.00 |
| Mar 31, 2026 | 42,414.00 |
| Dec 31, 2025 | 1.24 Mn |
API Access
Neuphoria Therapeutics Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();